Back to top

Jefferies says guidance suggests FDA receptive to helping psychedelic sponsors

Jefferies notes that on September 14, the FDA will host a public hearing to discuss “issues” associated with psychedelic drugs in supervised and su...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AtaiBeckley Inc (ATAI)

COMPASS Pathways PLC Sponsored ADR (CMPS)

Definium Therapeutics, Inc. (DFTX)

GH Research PLC (GHRS)

Cybin Inc. (HELP)